Authors: Sara A. Hurvitz, Miguel Martin, Kyung Hae Jung, et. al. Abstract: 500 Clinical Trial Registry Number: NCT02131064 Citation: J Clin Oncol 37, 2019 Background: KRISTINE compared neoadjuvant chemotherapy plus dual HER2- blockade (HP) with T-DM1 plus P (T-DM1+P), a targeted regimen that omits standard chemotherapy. T-DM1+P resulted in a lower...
Pro zobrazení tohoto obsahu je třeba být přihlášen.